The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-{4-[(3,5-Ditert-butyl-4-hydroxyphenyl)-phenyl-methyl]-piperazin-1-yl}-3,3-diphenyl-propan-1-one ID: ALA3927466
PubChem CID: 10257808
Max Phase: Preclinical
Molecular Formula: C40H48N2O2
Molecular Weight: 588.84
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1cc(C(c2ccccc2)N2CCN(C(=O)CC(c3ccccc3)c3ccccc3)CC2)cc(C(C)(C)C)c1O
Standard InChI: InChI=1S/C40H48N2O2/c1-39(2,3)34-26-32(27-35(38(34)44)40(4,5)6)37(31-20-14-9-15-21-31)42-24-22-41(23-25-42)36(43)28-33(29-16-10-7-11-17-29)30-18-12-8-13-19-30/h7-21,26-27,33,37,44H,22-25,28H2,1-6H3
Standard InChI Key: LHCKOUZHHLPSDY-UHFFFAOYSA-N
Molfile:
RDKit 2D
44 48 0 0 0 0 0 0 0 0999 V2000
15.5900 -10.8404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9986 -10.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8158 -10.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9986 -11.5454 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2244 -10.8404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0416 -10.8404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4502 -11.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0416 -12.2545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2244 -12.2545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8158 -11.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2244 -9.4222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8158 -8.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2244 -8.0082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0416 -8.0082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4502 -8.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0416 -9.4222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7728 -10.8404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3643 -11.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5471 -11.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1385 -10.8404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5471 -10.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3643 -10.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3213 -10.8404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9127 -11.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3213 -12.2545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9127 -12.9635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0955 -12.9635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6869 -12.2545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0955 -11.5454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9127 -10.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0955 -10.1313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6869 -9.4222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0955 -8.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9127 -8.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3213 -9.4222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6869 -8.0082 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.3213 -8.0082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8697 -9.4222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9139 -7.2998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1385 -8.0095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7242 -7.2969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4611 -8.7145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4611 -10.1299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0510 -9.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
5 10 2 0
3 5 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
3 11 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
17 22 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
24 29 2 0
23 24 1 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
30 35 2 0
33 36 1 0
34 37 1 0
32 38 1 0
23 30 1 0
20 23 1 0
1 17 1 0
37 39 1 0
37 40 1 0
37 41 1 0
38 42 1 0
38 43 1 0
38 44 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 588.84Molecular Weight (Monoisotopic): 588.3716AlogP: 8.44#Rotatable Bonds: 7Polar Surface Area: 43.78Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.73CX Basic pKa: 6.81CX LogP: 9.26CX LogD: 9.16Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.24Np Likeness Score: -0.55
References 1. (2004) Calcium channel inhibitors comprising benzhydril spaced from piperazine,